Kymera Therapeutics, Inc. (KYMR)
82.59
-3.52
(-4.09%)
USD |
NASDAQ |
Mar 05, 14:59
Kymera Therapeutics Price : 82.59 for March 5, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 144.28 |
| Regeneron Pharmaceuticals, Inc. | 762.28 |
| Revolution Medicines, Inc. | 98.93 |
| Structure Therapeutics, Inc. | 58.35 |
| Sanofi | 45.06 |
Price Related Metrics
| PS Ratio | 177.89 |
| PEG Ratio | -0.9351 |
| Price to Book Value | 3.762 |
| Earnings Yield | -4.45% |
| Market Cap | 5.942B |
| PEGY Ratio | -0.9351 |